Clinical trial

Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary…

NCT00156845 · Acusphere, Industry · Completed

Key facts

NCT number NCT00156845
Title Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary Angiography
Official title A Phase 3, International, Multicenter, Open-Label, Dual-Injection, Echocardiographic Imaging and Safety Study in Patients With Suspected Ischemic Heart Disease Undergoing Diagnostic Coronary Angiography (Real-Time Assessment of Myocardial Perfusion With Echocardiography: RAMP 2)
Lead sponsor Acusphere, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Coronary Artery Disease
Intervention type Procedure
Interventions AI-700 contrast-enhanced echocardiography
Enrollment 450
Start date Dec 1, 2003
Completion Jun 1, 2006
First posted Sep 12, 2005
Last update posted Jul 14, 2006
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies